Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2012 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer.
J Gen Intern Med. 2013 Nov;28(11):1440-6. doi: 10.1007/s11606-013-2477-2. Epub 2013 May 14.
J Gen Intern Med. 2013.
PMID: 23670565
Free PMC article.
Reducing bias in the assessment of treatment effectiveness: androgen deprivation therapy for prostate cancer.
Kuo YF, Montie JE, Shahinian VB.
Kuo YF, et al.
Med Care. 2012 May;50(5):374-80. doi: 10.1097/MLR.0b013e318245a086.
Med Care. 2012.
PMID: 22635250
Free PMC article.
Item in Clipboard
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
Gillessen S, Templeton A, Marra G, Kuo YF, Valtorta E, Shahinian VB.
Gillessen S, et al.
J Natl Cancer Inst. 2010 Dec 1;102(23):1760-70. doi: 10.1093/jnci/djq419. Epub 2010 Nov 10.
J Natl Cancer Inst. 2010.
PMID: 21068432
Free PMC article.
Item in Clipboard
High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?
Shahinian VB.
Shahinian VB.
Asian J Androl. 2012 May;14(3):419-20. doi: 10.1038/aja.2011.182. Epub 2012 Feb 6.
Asian J Androl. 2012.
PMID: 22306913
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite